ArticleThe Journal of pathology2023

Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.

Sarah E Tarullo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.